Drug Type Monoclonal antibody |
Synonyms PRX012-TfR |
Target |
Action modulators |
Mechanism TfR1 modulators(Transferrin receptor protein 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | Ireland | 30 Sep 2025 |






